Wird geladen...
Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
The binding of the tumor necrosis factor α (TNFα) to its cognate receptor initiates many immune and inflammatory processes. The drugs, etanercept (Enbrel(®)), infliximab (Remicade(®)), adalimumab (Humira(®)), certolizumab-pegol (Cimzia(®)), and golimumab (Simponi(®)), are anti-TNFα agents. These dru...
Gespeichert in:
| Veröffentlicht in: | Int J Mol Sci |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5877629/ https://ncbi.nlm.nih.gov/pubmed/29518978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19030768 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|